Diffuse low-grade glioma: What is the optimal linear measure to assess tumor growth?
Dos Santos T, Deverdun J, Chaptal T, Darlix A, Duffau H, Van Dokkum LEH, Coget A, Carrière M, Denis E, Verdier M, Menjot de Champfleur N, Le Bars E.
Dos Santos T, et al. Among authors: van dokkum leh.
Neurooncol Adv. 2024 Mar 27;6(1):vdae044. doi: 10.1093/noajnl/vdae044. eCollection 2024 Jan-Dec.
Neurooncol Adv. 2024.
PMID: 39071735
Free PMC article.